• Earlier in January, Mosaic extended production curtailments for single superphosphate at its Fospar and Araxá plants in Brazil and reported weaker-than-expected preliminary Q4 2025 results, citing high sulfur costs and a sharp drop in North American phosphate demand.
• Together, these actions highlight how input cost pressures and softer regional fertilizer demand are simultaneously weighing on Mosaic’s operations and product mix decisions.
• Against this backdrop, we’ll examine how Mosaic’s extended Brazilian production cuts shape the company’s investment narrative for investors today.

AI is about to change healthcare. These 111 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

What Is Mosaic's Investment Narrative?

To own Mosaic today, you really need to believe in the long-term need for phosphate and potash, while accepting that earnings can swing when crop prices, farmer budgets and input costs move against it. The latest update reinforces that tension. The extended SSP curtailments in Brazil and weak preliminary Q4 2025 snapshot underline how quickly sulfur prices and North American demand can squeeze margins, even after a year of higher earnings and ongoing dividends. In the near term, key catalysts now sit around the February Q4 release, any color on sulfur procurement and Brazilian utilization, and whether potash stability can offset softer phosphates. At the same time, recent analyst target increases and insider buying point to some confidence that current pressures may already be reflected in the share price.

Although Mosaic looks inexpensive on earnings, sulfur and demand shocks can quickly change that picture. Mosaic's shares are on the way up, but they could be overextended by 23%. Uncover the fair value now.

Exploring Other Perspectives

Five Simply Wall St Community fair value estimates for Mosaic span roughly US$22.98 to US$36.85, showing how far apart individual views can be. Against that backdrop, the recent hit from softer North American phosphates and high sulfur costs gives you a concrete example of why these investors can reach very different conclusions about Mosaic’s earnings resilience and future performance.

Explore 5 other fair value estimates on Mosaic - why the stock might be worth as much as 31% more than the current price!

Build Your Own Mosaic Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Mosaic research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Mosaic research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Mosaic's overall financial health at a glance.

Interested In Other Possibilities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.